LQ-007

N/A

Report date: 2023/02/28 10:38:10

Base Information

Drug NameLQ-007

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Cluster of differentiation 47

TargetsCluster of differentiation 47

Therapy Area/IndicationsOvarian NeoplasmsLymphoma, Non-Hodgkin

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesShanghai Novamab Biopharmaceuticals Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Novamab Biopharmaceuticals Co Ltd

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsLymphoma, Non-Hodgkin

Inactive IndicationsN/A

Other Information

ATC CodeN/A